ACQUIRING LABS
CREATING VALUE

Operationally-driven private investment firm specializing in buyout and consolidation of high-quality US-based medical laboratories with $1M+ EBITDA.

PRACTICE AREAS

INVESTMENT
CRITERIA

TARGET SIZE

We target companies with EBITDA between $1M and $5M

INVESTMENT TYPE

Control acquisitions of sub-scaled, under-managed, owner-operated laboratories

TRANSACTION TYPES

LBOs, add-ons, consolidations, generational transitions, MBOs

INVESTMENT RANGE

Typically $5M to $10M with flexibility to pursue outside of this range

OWNERSHIP

Control investor requiring significant owner rollover

ROLE

We are a highly active, deeply engaged, majority board member

OUR VISION

OUR APPROACH

As an operationally-focused private investment firm, we specialize in the strategic buyout and consolidation of high-performing medical laboratories based in the US with $1M+ EBITDA, leveraging our expertise and resources to unlock their full potential and drive sustainable growth.

As seasoned professionals in the lab industry, we recognize and appreciate the success you've achieved thus far. We also understand the challenges of scaling your business to the next level, maintaining its legacy, providing growth opportunities for your team, and diversifying your personal wealth. By partnering with us, you can leverage our expertise, resources, and industry connections to achieve these goals and take your lab to new heights of success.

Our goal is to unlock the full potential of your business by strategically placing the right people in the right roles and providing them with the resources and support they need to excel. Through this process, we transform entrepreneurial businesses into thriving, resilient, and professionally managed organizations that create long-term value for all stakeholders.

OUR EDGE

Our unique combination of sector focus, coupled with our founding team's industry experience and deep engagement strategy, allows us to compete where and how others cannot.

Specialized Sector Expertise

We acquire targets that are too small for larger buyout firms, not yet strategic enough for public companies, and too complex for inexperienced, small buyers. With a portfolio of top-tier talent, we're uniquely positioned to mitigate key person risk and drive the long-term success of our acquisitions.

Proprietary Deal Sourcing

With a proven track record of brokering more lab deals than any other team in the country, we have established strong relationships with lab owners that grant us unparalleled access to off-market deal flow and countless buying opportunities. This gives us a first look at high-quality labs with significant growth potential.

Deep Engagement

At the heart of our approach is a highly active, operationally-focused strategy that prioritizes professional management practices and strong governance throughout our portfolio of companies. By leveraging our extensive experience and resources, we drive sustainable growth and value creation, ensuring that each of our portfolio companies reaches its full potential.

ATTORNEYS

OUR TEAM

Our team at Demeter Capital Partners brings together a wealth of experience in the lab industry. Our deal-making skills and operational capabilities enable us to create value for our investors by identifying and executing strategic opportunities. With a deep understanding of the industry and a track record of success, our team is committed to delivering exceptional results for our partners.